Dr Safaa Alsanosi

  • Affiliate (School of Cardiovascular & Metabolic Health)

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2022 | 2017
Number of items: 10.

2024

Alsanosi, S. M. and Padmanabhan, S. (2024) Potential applications of artificial intelligence (AI) in managing polypharmacy in Saudi Arabia: a narrative review. Healthcare, 12(7), 788. (doi: 10.3390/healthcare12070788)

2023

Alsanosi, S. M., Mousa, A. H., Ahmadini, H. A., Qadhi, R. S., Ikram, N., Felemban, A. H., Alqashqri, H. S., Hariri, N. H., Alhindi, Y. Z. and Ayoub, N. (2023) Polypharmacy among patients with hypertension attending primary healthcare centres. Annals of Medicine and Surgery, 85(6), pp. 2545-2549. (doi: 10.1097/MS9.0000000000000818) (PMID:37363582) (PMCID:PMC10289761)

Du Toit, C. et al. (2023) Survey and evaluation of hypertension machine learning research. Journal of the American Heart Association, 12(9), e027896. (doi: 10.1161/JAHA.122.027896) (PMID:37119074) (PMCID:PMC10227215)

Mirdad, O. A., Esheba, G. E., Mousa, A. H., Nukaly, H. Y., Alhindi, Y. Z., Hariri, N. H., Ayoub, N. and Alsanosi, S. M. (2023) Over-the-counter medication use among parents in Saudi Arabia. International Journal of Environmental Research and Public Health, 20(2), 1193. (doi: 10.3390/ijerph20021193) (PMID:36673949) (PMCID:PMC9858867)

2022

Alosaimi, K., Alwafi, H., Alhindi, Y., Falemban, A., Alshanberi, A., Ayoub, N. and Alsanosi, S. (2022) Medication adherence among patients with chronic diseases in Saudi Arabia. International Journal of Environmental Research and Public Health, 19(16), 10053. (doi: 10.3390/ijerph191610053) (PMID:36011690) (PMCID:PMC9408114)

Althobaiti, F. M. et al. (2022) Efficacy and safety of empagliflozin in type 2 diabetes mellitus Saudi patients as add-on to antidiabetic therapy: a prospective, open-label, observational study. Journal of Clinical Medicine, 11(16), 4769. (doi: 10.3390/jcm11164769) (PMID:36013008) (PMCID:PMC9410062)

Du Toit, C. et al. (2022) Investigating the quality of machine learning research and reporting in hypertension. European Society of Hypertension 31st Annual Meeting, Athens, Greece, 17-21 Jul 2022. e78. (doi: 10.1097/01.hjh.0000835956.81410.5e)

Ayoub, N., Badr, N., Al-Ghamdi, S. S., Alsanosi, S., Alzahrani, A. R., Abdel-Naim, A. B., Nematallah, K. A. and Swilam, N. (2022) HPLC/MS n profiling and healing activity of a muco-adhesive formula of Salvadora persica against acetic acid-induced oral ulcer in rats. Nutrients, 14(1), 28. (doi: 10.3390/nu14010028) (PMID:35010903) (PMCID:PMC8746813)

Alsanosi, S. M. (2022) A new vision of teaching clinical pharmacology and therapeutics for undergraduate medical students. Advances in Medical Education and Practice, 13, pp. 567-575. (doi: 10.2147/AMEP.S359704) (PMID:35656121) (PMCID:PMC9153941)

2017

Che Roos, N. A., Alsanosi, S. M., Alsieni, M. A., Gupta, M. and Padmanabhan, S. (2017) Antihypertensive Drugs and Risk of Cancer: A Systematic Review and Meta-Analysis of 391, 790 Patients. The American Heart Association's Hypertension 2017 Scientific Sessions, San Francisco, CA, USA, 14-17 Sep 2017. (doi: 10.1161/hyp.70.suppl_1.p129)

This list was generated on Wed May 29 16:03:59 2024 BST.
Number of items: 10.

Articles

Alsanosi, S. M. and Padmanabhan, S. (2024) Potential applications of artificial intelligence (AI) in managing polypharmacy in Saudi Arabia: a narrative review. Healthcare, 12(7), 788. (doi: 10.3390/healthcare12070788)

Alsanosi, S. M., Mousa, A. H., Ahmadini, H. A., Qadhi, R. S., Ikram, N., Felemban, A. H., Alqashqri, H. S., Hariri, N. H., Alhindi, Y. Z. and Ayoub, N. (2023) Polypharmacy among patients with hypertension attending primary healthcare centres. Annals of Medicine and Surgery, 85(6), pp. 2545-2549. (doi: 10.1097/MS9.0000000000000818) (PMID:37363582) (PMCID:PMC10289761)

Du Toit, C. et al. (2023) Survey and evaluation of hypertension machine learning research. Journal of the American Heart Association, 12(9), e027896. (doi: 10.1161/JAHA.122.027896) (PMID:37119074) (PMCID:PMC10227215)

Mirdad, O. A., Esheba, G. E., Mousa, A. H., Nukaly, H. Y., Alhindi, Y. Z., Hariri, N. H., Ayoub, N. and Alsanosi, S. M. (2023) Over-the-counter medication use among parents in Saudi Arabia. International Journal of Environmental Research and Public Health, 20(2), 1193. (doi: 10.3390/ijerph20021193) (PMID:36673949) (PMCID:PMC9858867)

Alosaimi, K., Alwafi, H., Alhindi, Y., Falemban, A., Alshanberi, A., Ayoub, N. and Alsanosi, S. (2022) Medication adherence among patients with chronic diseases in Saudi Arabia. International Journal of Environmental Research and Public Health, 19(16), 10053. (doi: 10.3390/ijerph191610053) (PMID:36011690) (PMCID:PMC9408114)

Althobaiti, F. M. et al. (2022) Efficacy and safety of empagliflozin in type 2 diabetes mellitus Saudi patients as add-on to antidiabetic therapy: a prospective, open-label, observational study. Journal of Clinical Medicine, 11(16), 4769. (doi: 10.3390/jcm11164769) (PMID:36013008) (PMCID:PMC9410062)

Ayoub, N., Badr, N., Al-Ghamdi, S. S., Alsanosi, S., Alzahrani, A. R., Abdel-Naim, A. B., Nematallah, K. A. and Swilam, N. (2022) HPLC/MS n profiling and healing activity of a muco-adhesive formula of Salvadora persica against acetic acid-induced oral ulcer in rats. Nutrients, 14(1), 28. (doi: 10.3390/nu14010028) (PMID:35010903) (PMCID:PMC8746813)

Alsanosi, S. M. (2022) A new vision of teaching clinical pharmacology and therapeutics for undergraduate medical students. Advances in Medical Education and Practice, 13, pp. 567-575. (doi: 10.2147/AMEP.S359704) (PMID:35656121) (PMCID:PMC9153941)

Conference or Workshop Item

Du Toit, C. et al. (2022) Investigating the quality of machine learning research and reporting in hypertension. European Society of Hypertension 31st Annual Meeting, Athens, Greece, 17-21 Jul 2022. e78. (doi: 10.1097/01.hjh.0000835956.81410.5e)

Che Roos, N. A., Alsanosi, S. M., Alsieni, M. A., Gupta, M. and Padmanabhan, S. (2017) Antihypertensive Drugs and Risk of Cancer: A Systematic Review and Meta-Analysis of 391, 790 Patients. The American Heart Association's Hypertension 2017 Scientific Sessions, San Francisco, CA, USA, 14-17 Sep 2017. (doi: 10.1161/hyp.70.suppl_1.p129)

This list was generated on Wed May 29 16:03:59 2024 BST.